D. Kern

发表

FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens

K. Okuno, P. Greenberg, C. Holt, 1989, The Journal of experimental medicine.

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

P. Greenberg, M. Cheever, D. Kern, 1985, The Journal of experimental medicine.

Specific Adoptive Therapy of Disseminated Tumors

P. Greenberg, M. Cheever, M. Jensen, 1987 .

Specific Adoptive Therapy of Disseminated Tumors Requirements for Therapeutic Efficacy and Mechanisms by Which T Cells Mediate Tumor Eradication

P. Greenberg, M. Cheever, M. Jensen, 1987 .

Analysis of T-Cell Receptor Gene Rearrangement in Lymph Nodes of Patients With Mycosis Fungoides

J. Olerud, R. Moe, D. Kern, 2015 .

Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.

J. Olerud, R. Moe, D. Kern, 1998, Archives of dermatology.

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.

J. Thompson, P. Greenberg, J. Treisman, 1990, Cancer research.

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.

J. Thompson, P. Greenberg, D. Peace, 1986, Journal of immunology.

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.

J. Thompson, S. Gillis, A. Fefer, 1989, Cancer research.

Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

C. Henney, K. Kuribayashi, S. Gillis, 1981, Journal of immunology.

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.

P. Greenberg, D. Peace, M. Cheever, 1988, Journal of immunology.

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth.

J. Thompson, P. Greenberg, M. Cheever, 1985, Journal of immunology.

The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.

C. Henney, S. Gillis, M. Okada, 1981, Journal of immunology.

Specific adoptive immunotherapy.

K. Okuno, S. Riddell, P. Greenberg, 1989, Progress in clinical and biological research.

Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.

J. Thompson, L. Matis, P. Greenberg, 1987, Journal of immunology.

Interleukin-2 augments natural killer cell activity

C. Henney, K. Kuribayashi, S. Gillis, 1981, Nature.

The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.

S. Ziegler, E. Mulvihill, R. Gelinas, 1997, The Journal of investigative dermatology.

Relationship between in vivo mitomycin c exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. II. Effect of aging on spleen cell mitogenesis and sister chromatid exchange induction

E. Schneider, P. Mann, D. Kern, 1981, Mechanisms of Ageing and Development.

Therapy of disseminated tumors by adoptive transfer of specifically immune T cells.

P. Greenberg, M. Cheever, J. Klarnet, 1988, Progress in experimental tumor research.

INTERLEUKIN-2 AND THE REGULATION OF CYTOTOXIC CELLS

C. Henney, S. Gillis, D. Kern, 1983 .

Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.

P. Greenberg, M. Jensen, J. Klarnet, 1986, Journal of immunology.

Requirements for T cell recognition and elimination of retrovirally-transformed cells.

K. Okuno, S. Riddell, P. Greenberg, 1988, Princess Takamatsu symposia.

Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.

L. Matis, P. Greenberg, M. Cheever, 1989, Journal of immunology.

Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.

K. Okuno, R. Schreiber, P. Greenberg, 1989, Journal of immunology.

Effector mechanisms by which adoptively transferred T cells promote tumor eradication.

P. Greenberg, M. Cheever, M. Jensen, 1987, Progress in clinical and biological research.

Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo.

J. Thompson, P. Greenberg, M. Cheever, 1984, Journal of biological response modifiers.

Cytotoxic responses: the regulatory influence of interleukin-2.

C. Henney, S. Gillis, D. Kern, 1982, Transplantation Proceedings.

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

M. Cheever, D. Kern, Philip D. Greenberg, 1985, The Journal of experimental medicine.

Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.

P. Greenberg, L. Lachmann, D. Kern, 1987, Journal of immunology.

Relationship between in vivo mitomycin c exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. I. Development of murine splenic cell system

E. Schneider, P. Mann, D. Kern, 1981, Mechanisms of Ageing and Development.